UC Davis Health’s Tiffany Phung, Pharm.D., and Tim Cutler, Pharm.D., say staff-driven ideas protect research independence in industry partnerships.
News|Articles|May 24, 2024
Paul Kelly on PBM Reform as a Means to an End: A 'Pay For' for Telehealth Flexibilities
Author(s)Peter Wehrwein, Managing Editor
Although bills that would make comprehensive changes to the PBM industry have advanced in Congress, Paul Kelly, a veteran healthcare lobbyist, says a limited version that saves Medicare money may pass as an offsetting "pay for" for extension of more liberal rules for telehealth services that Medicare covers.
Advertisement
Paul Kelly, of Capitol Advocacy & Government Affairs, LLC and a veteran healthcare lobbyist in Washington, D.C., says that a limited version of PBM reform may pass Congress after the November election that serves as a "pay for" for the extension of the Medicare telehealth flexibilities that were permitted during the COVID-19 public health emergency.
Kelly says the House Ways and Means has OKed a two-year extension of the telehealth flexibilities that includes some limited PBM reform provisions as a way of offsetting the costs of liberalizing the rules for telehealth services that Medicare will cover.
Advertisement
Related to this article
UC Davis Health’s Tiffany Phung, Pharm.D., and Tim Cutler, Pharm.D., say research justifies services and opens doors to limited distribution drugs.
Garza, an expert on hidradenitis suppurativa at Johns Hopkins, says increasing incidence of the disease on the Japanese island of Okinawa offer some "tantalizing clues" about reasons for the rising incidence.
Apothecary Pharma is recalling 22 vials of compounded tirzepatide and one NAD+ vial nationwide, citing a lack of assurance of sterility.
Pooja Roy, M.D., of Houston Methodist Hospital, discusses how Precedex (dexmedetomidine), an ICU sedative, sometimes triggers noninfectious fever, sparking costly sepsis workups, and the need for a test could help clinicians identify the drug as a cause of fever in ICUs.
Pope Leo early-stage adenocarcinoma is a reminder that lung nodules often cause no symptoms and that people who never smoked can get lung cancer.
Young-onset lung cancer often strikes nonsmokers, and current screening based on smoking is not likely to find it, says Singhi, an assistant professor at UT MD Anderson Cancer Center in Houston. New risk-based screening, liquid biopsies, and breath tests aim earlier detection.
Rex Hoffman, M.D., MBA, says physician shortages and burnout are the most underestimated pressures on health system.
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Rex Hoffman, M.D., on physician burnout and collaborative leadership | HSES 2026
2
Rex Hoffman, M.D., on how a CMO balances competing priorities | HSES 2026
3
GLP-1 therapy tied to lower mortality and liver decompensation in older adults with MASLD
4
Algia Pharma completes investigational drug toxicology study for non-opioid acute pain regimen AlgiaPak
5